Tigecycline for treatment of nosocomial-acquired pneumonia possibly caused by multi-drug resistant strains of Stenotrophomonas maltophilia

J Chemother. 2008 Dec;20(6):761-3. doi: 10.1179/joc.2008.20.6.761.

Authors

D Blanquer¹, J De Otero, E Padilla, F Gómez, A Mayol, R Irigaray, P Espejo, M A Rada, G Makrantoni, A R Pérez

Affiliation

¹ Pneumology, Hospital de Manacor, Balearic Islands, Spain. davidovichbe03@yahoo.es

PMID: 19129079
DOI: 10.1179/joc.2008.20.6.761

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Anti-Bacterial Agents / therapeutic use*
Carcinoma, Transitional Cell / complications
Cross Infection / complications
Cross Infection / drug therapy*
Cross Infection / physiopathology
Drug Resistance, Multiple
Emphysema / complications
Gram-Negative Bacterial Infections / complications
Gram-Negative Bacterial Infections / drug therapy*
Gram-Negative Bacterial Infections / physiopathology
Humans
Lupus Erythematosus, Discoid / complications
Male
Minocycline / analogs & derivatives*
Minocycline / therapeutic use
Obesity / complications
Pneumonia, Bacterial / complications
Pneumonia, Bacterial / drug therapy*
Pneumonia, Bacterial / physiopathology
Pulmonary Disease, Chronic Obstructive / complications
Stenotrophomonas maltophilia / drug effects*
Tigecycline
Urinary Bladder Neoplasms / complications

Substances

Anti-Bacterial Agents
Tigecycline
Minocycline